Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Breast Carcinoma In Situ × talimogene laherparepvec × 30 days × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 1 Sezary Syndrome 1 Sarcoma 1 Paget Disease, Extramammary 1 Mycosis Fungoides 1 Muir-Torre Syndrome 1 Microcystic adnexal carcinoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Eccrine Porocarcinoma 1 Carcinoma, Signet Ring Cell 1 Carcinoma, Merkel Cell 1 Carcinoma, Ductal, Breast 1 Carcinoma, Ductal 1 Carcinoma, Basosquamous 1 Carcinoma, Basal Cell 1 Breast Neoplasms 1 Adenocarcinoma, Papillary 1

Interventions

Tamoxifen 3 Specimen Handling 3 pembrolizumab 1 exemestane 1 Watchful Waiting 1 Starch 1 Standard of Care 1 Radiotherapy 1 Radiation 1 Practice Guidelines as Topic 1 Observation 1 Magnetic Resonance Spectroscopy 1 Letrozole 1 Biopsy 1 Anastrozole 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡